Immediate Impact
55 standout
Citing Papers
Extracellular matrix remodeling in the tumor immunity
2024 Standout
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
2024 Standout
Works of Shu‐Chih Su being referenced
Abstract CT042: Pembrolizumab 400 mg Q6W dosing: First clinical outcomes data from Keynote-555 cohort B in metastatic melanoma patients
2020
KEYNOTE-119: A randomized phase III study of single-agent pembrolizumab (MK-3475) vs single-agent chemotherapy per physician's choice for metastatic triple-negative breast cancer (mTNBC).
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shu‐Chih Su | 202 | 53 | 10 | 61 | 14 | 302 | |
| S. W. Wassilew | 249 | 26 | 32 | 50 | 19 | 298 | |
| A. Faherty | 238 | 37 | 13 | 29 | 13 | 297 | |
| J. Portnoy | 183 | 53 | 14 | 17 | 18 | 315 | |
| Margaret K. S. Ridehalgh | 281 | 11 | 5 | 28 | 14 | 336 | |
| A Linde | 206 | 106 | 4 | 16 | 17 | 322 | |
| Adriana Bastidas | 84 | 9 | 7 | 30 | 12 | 259 | |
| Karl E. Schneweis | 220 | 16 | 17 | 15 | 294 | ||
| Alberto Spanò | 181 | 15 | 2 | 8 | 18 | 360 | |
| Francis K. Lee | 182 | 16 | 28 | 10 | 307 | ||
| J. Leszczynski | 320 | 24 | 3 | 36 | 7 | 351 |
All Works
Login with ORCID to disown or claim papers
Loading papers...